CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- 4/A Open-market sale Chief Financial Officer sold 2,012 shares at $11.16 ($22,454)
- 4/A Open-market sale President, R&D sold 2,850 shares at $11.16 ($31,806)
- 4/A Open-market sale Chief Legal Officer sold 1,936 shares at $11.16 ($21,606)
- 8-K Event Shareholder vote results
- 4 Gift Director gave 12,099 shares (gift)
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale See remarks sold 739 shares at $11.16 ($8,247)
- 4 Open-market sale Chief Financial Officer sold 863 shares at $11.16 ($9,631)
- 4 Open-market sale President, R&D sold 1,383 shares at $11.16 ($15,434)
- 4 Open-market sale Chief Legal Officer sold 863 shares at $11.16 ($9,631)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market sale See remarks sold 297 shares at $15.36 ($4,562)
- 4 Open-market sale Chief Financial Officer sold 347 shares at $15.36 ($5,330)
- 4 Open-market sale President, R&D sold 763 shares at $15.36 ($11,720)
- 4 Open-market sale Chief Legal Officer sold 347 shares at $15.36 ($5,330)
Page 16 of 28 · 556 filings